Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine wether a rituximab-based treatment compared to
standard therapy (glucocorticoid alone) in patients with microscopic polyangiitis without any
bad prognosis marker increases the remission and reduces the relapse free survival rate.